Loading...

TAOX TAO SYNERGIES INC Expansion Plans 8-K Filing

T SY

TX

TAO SYNERGIES INC

(TAOX)

2023 8-K

Annual Meeting Results

Funding Announcement

Management Changes

Asset Acquisitions

Asset Acquisitions

Pre-Market Approval

Equity Offerings

Management Changes

Annual Meeting Results

Preferred Stock Issuance

Stock Amendment

CEO Employment Extension

Reverse Stock Split

Annual Meeting and Plan Ame...

Share Purchase Agreement wi...

Amendment to Certificate of...

Management Extension

Special Meeting of Stockhol...

Financial Condition

Special Meeting Adjourned

External Links:

Synaptogenix, Inc. announced its agreement with Cleveland Clinic to start phase 1 trials of Bryostatin-1 in multiple sclerosis on 19th July 2023.

AI Assistant

TAO SYNERGIES INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.